Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

Artificial intelligence (AI)-based algorithms that use electrocardiogram (ECG) data have high accuracy in predicting ...

A quick heart trace taken during a warm-up trot could identify racehorses at risk of cardiac arrhythmias during ...

PH is a progressive, life-threatening pulmonary vascular disease estimated to affect up to 1% of the global population. 1 It is often difficult to diagnose 2 due to non-specific early symptoms, such ...

An artificial intelligence (AI)-based method for interpreting ECGs performed better than standard approaches in detecting occlusive myocardial infarction (MI), according to a study presented at ESC ...

A quick heart trace taken during a warm-up trot could identify racehorses at risk of cardiac arrhythmias during ...

Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...

Once submitted, the ECG is evaluated within 24 hours by a Canadian-registered cardiologist from WELL Health's network. Each review provides a more comprehensive clinical evaluation to confirm or ...

Collaboration Expands Reach of MaxYield™ into Remote Heart Monitoring and Preventive Cardiology Applications TORONTO, ON / ...

The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate AI-based ECG Algorithms The collaboration is focused on building next-generation, ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...